View in EDS HTML Full Text PDF Full Text

Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.

Saved in:
Bibliographic Details
Title: Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.
Authors: Nagpal S; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA., Nguyen KS; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Bertrand S; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA., Cunanan KM; Quantitative Sciences Unit, School of Medicine, Stanford University, Stanford, California, USA., Padda SK; Fox Chase Cancer Center, Temple University, Philadelphia, Pennsylvania, USA., Pagtama JY; Stanford Health Care, Stanford, California, USA., Tisch AH; Stanford Health Care, Stanford, California, USA., Coffey G; Stanford Health Care, Stanford, California, USA., Thomas RP; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA., Sledge GW Jr; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Gruber J; UT Southwestern Medical Center, Dallas, Texas, USA., Telli ML; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Pegram M; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Recht LD; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA., Wakelee HA; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Soltys SG; Department of Radiation Oncology, Stanford University, Stanford, California, USA., Massarweh SA; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA., Neal JW; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.
Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2025 Sep; Vol. 8 (9), pp. e70330.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40877204
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nagpal+S%22">Nagpal S</searchLink>; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+KS%22">Nguyen KS</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Bertrand+S%22">Bertrand S</searchLink>; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Cunanan+KM%22">Cunanan KM</searchLink>; Quantitative Sciences Unit, School of Medicine, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Padda+SK%22">Padda SK</searchLink>; Fox Chase Cancer Center, Temple University, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Pagtama+JY%22">Pagtama JY</searchLink>; Stanford Health Care, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Tisch+AH%22">Tisch AH</searchLink>; Stanford Health Care, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Coffey+G%22">Coffey G</searchLink>; Stanford Health Care, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+RP%22">Thomas RP</searchLink>; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Sledge+GW+Jr%22">Sledge GW Jr</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Gruber+J%22">Gruber J</searchLink>; UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Telli+ML%22">Telli ML</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Pegram+M%22">Pegram M</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Recht+LD%22">Recht LD</searchLink>; Department of Neurology, Division of Neuro-Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Wakelee+HA%22">Wakelee HA</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Soltys+SG%22">Soltys SG</searchLink>; Department of Radiation Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Massarweh+SA%22">Massarweh SA</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Neal+JW%22">Neal JW</searchLink>; Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101747728%22">Cancer reports (Hoboken, N.J.)</searchLink> [Cancer Rep (Hoboken)] 2025 Sep; Vol. 8 (9), pp. e70330.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101747728 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2573-8348 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225738348%22">25738348 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Rep (Hoboken) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40877204
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cnr2.70330
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70330
    Titles:
      – TitleFull: Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nagpal S
      – PersonEntity:
          Name:
            NameFull: Nguyen KS
      – PersonEntity:
          Name:
            NameFull: Bertrand S
      – PersonEntity:
          Name:
            NameFull: Cunanan KM
      – PersonEntity:
          Name:
            NameFull: Padda SK
      – PersonEntity:
          Name:
            NameFull: Pagtama JY
      – PersonEntity:
          Name:
            NameFull: Tisch AH
      – PersonEntity:
          Name:
            NameFull: Coffey G
      – PersonEntity:
          Name:
            NameFull: Thomas RP
      – PersonEntity:
          Name:
            NameFull: Sledge GW Jr
      – PersonEntity:
          Name:
            NameFull: Gruber J
      – PersonEntity:
          Name:
            NameFull: Telli ML
      – PersonEntity:
          Name:
            NameFull: Pegram M
      – PersonEntity:
          Name:
            NameFull: Recht LD
      – PersonEntity:
          Name:
            NameFull: Wakelee HA
      – PersonEntity:
          Name:
            NameFull: Soltys SG
      – PersonEntity:
          Name:
            NameFull: Massarweh SA
      – PersonEntity:
          Name:
            NameFull: Neal JW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2573-8348
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer reports (Hoboken, N.J.)
              Type: main
ResultId 1